Trials / Completed
CompletedNCT00956917
Comparison Study for Bioelectrical Impedance Device to Measure Human Body Composition
Comparison of Impedance Components and Estimated Body Composition Variables Determined by Using Bioelectrical Impedance Devices Manufactured by Akern SRL and RJL Systems
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Akern USA LLC · Industry
- Sex
- All
- Age
- 16 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if the ElectroFluidGraph(tm) (EFG) impedance analyzer is comparable to a predicate device in measuring human body composition.
Detailed description
The purpose of this study is to determine if the ElectroFluidGraph(tm) (EFG) impedance analyzer is comparable to a predicate device in measuring human body composition under normal patient conditions. Specifically, the goal of this study is to compare impedance measurements (R and Xc) determined by using each bioelectrical impedance device and the estimated body compositional estimates \[total body water (TBW); fat-free mass (FFM); and fat mass (FM)\] calculated by using the same prediction equation (models) as the predicate device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Akern USA EFG | Impedance measurement device |
| DEVICE | RJL Impedance analyzer | Impedance analyzer |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2009-08-11
- Last updated
- 2009-08-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00956917. Inclusion in this directory is not an endorsement.